by andyhopkinson | Apr 16, 2018 | News
This year has so far consisted of a number of significant additions to the NuVision team. This month, we are delighted to announce the appointment of our new Sales and Marketing Director, Jonathan Hamill-Keays, who will lead and work alongside our new Territory...
by andyhopkinson | Mar 29, 2018 | News
NuVision Biotherapies is delighted to announce that Roger Teasdale has joined the Board as an Independent Non-Executive Director. Roger enjoyed a successful 25 year career at Smith & Nephew, the FTSE 100 Medical device business focused on the Advanced Wound...
by andyhopkinson | Mar 2, 2018 | News
NuVision Biotherapies is delighted to announce the appointment of its new chairman, Dr Mark Treherne. Mark has a PhD in Pharmacology from Cambridge University along with over 25 years of industrial R&D experience in the discovery and development of novel...
by andyhopkinson | Feb 15, 2018 | News
NuVision Biotherapies is delighted to announce the recent completion of a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham. The investment will enable the company to increase sales both in the UK and to develop...
by andyhopkinson | Jan 10, 2018 | News
We are currently inviting applications for opportunities with the Commercial Specialist Team. We have opportunities on the following territories: Southern England London and East Anglia Midlands North England About NuVision Biotherapies This is your chance to join one...
